AI summary · may contain errors
Access to cancer genomics and precision oncology is profoundly unequal across and within countries, leaving millions of patients without guideline-indicated interventions each year.
- 1 cited this week
Moving in The Lancet Oncology.
Rebuilt
AI summary · may contain errors
Access to cancer genomics and precision oncology is profoundly unequal across and within countries, leaving millions of patients without guideline-indicated interventions each year.
Newest first · last 60 days
AI summary · may contain errors
A TNBC digital twin framework predicts treatment responses and links mutational and transcriptional biomarkers to clinical outcome in PARTNER, a randomized trial of platinum chemotherapy ± PARP inhibitors.
AI summary · may contain errors
Longitudinal cfDNA methylation cancer detection (CD) predicts pathological complete response and disease-free survival in 70 patients with esophageal squamous cell carcinoma, with post-NAT CD-negative linked to HR 0.33.
AI summary · may contain errors
KRAS Q61-mutant non-small cell lung cancer shows clinically relevant differences between Q61 alleles, emphasizing that genomic context matters for interpreting these mutations.
AI summary · may contain errors
CDKN2A/MTAP deletion (CMdel) occurs in 11.7% of NSCLC patients and defines a genomically distinct subset enriched for actionable drivers and worse outcomes on ICI/chemotherapy.
AI summary · may contain errors
MTAP loss is among the most common potentially targetable driver mutations in non-small cell lung cancer (NSCLC), supporting ongoing early-phase trials.
AI summary · may contain errors
Clair3-RNA showed the broadest, most robust small-variant calling applicability across ONT and PacBio lrRNA-seq chemistries, outperforming no single caller overall but spanning contexts.
AI summary · may contain errors
Multimodal composite scoring detected ctDNA in 70% of CSF versus 17% of plasma samples from 28 pediatric CNS tumor patients, outperforming any single modality alone.
AI summary · may contain errors
RESCUE, a multi-agent LLM workflow in a pediatric hospital EHR, achieved AUC 0.808 on a holdout set of n=12,591 and flagged higher genomic-assessment follow-up.
AI summary · may contain errors
A phase 2 cell-free DNA fragmentomics signature biomarker validation in two populations (Guatemala and Romania) showed promising performance for early-stage hepatocellular carcinoma detection when combined with serum alpha-fetoprotein and demographics.
AI summary · may contain errors
A single heterozygous carrier of MUTYH p.Gly396Asp shows SBS18 across multiple normal tissues, ranking first among 25 SMaHT donors.
AI summary · may contain errors
MOTET jointly infers multimodal mutational processes in 2,583 PCAWG whole genomes, recovering known MPs more accurately than standard post hoc correlation methods.
AI summary · may contain errors
SpOTr integrates single-cell and spatial transcriptomics in tumors by using Fused Gromov-Wasserstein optimal transport, recovering clone spatial locations better than tree-agnostic methods.
AI summary · may contain errors
Genome-wide profiling of DNA from red blood cell preparations (rbcDNA) shows encouraging performance for early detection of gastric cancer across multicenter cohorts.
AI summary · may contain errors
The ACMG/CAP technical standard for prenatal maternal plasma cfDNA screening establishes uniform laboratory validation, monitoring, and reporting practices for chromosome abnormalities.
AI summary · may contain errors
Histological transformation is a key resistance mechanism in precision oncology, linked to tumor plasticity that can erode clinical benefit after initial success with targeted therapies.
AI summary · may contain errors
Low-order multimerization of cytoplasmic RTK fusions drives strong Ras-Erk signalling and transformation without mesoscale condensation, including for EML4-ALK where signalling poorly correlates with condensates.
AI summary · may contain errors
Activating NMDe variants in cancer genes were identified as 12 genes showing two recurrent patterns, including frameshift C-terminal fragments (e.g., CALR) and truncations removing inhibitory regions (e.g., PPM1D).
AI summary · may contain errors
RNA sequencing of 1,824 lung cancer tumors defines nine transcriptional clusters spanning adenocarcinoma, squamous, and small cell, including a neuroendocrine-like adenocarcinoma group.
AI summary · may contain errors
A classifier using genome-wide rbcDNA read-depth features detects early-stage gastric cancer with 83%–90% overall sensitivity and 82%–89% sensitivity for stage I across three multicenter cohorts.
AI summary · may contain errors
Optical mapping of lung tissues across stages shows CGRs often form through hierarchical nested structural variations, yielding a chromodiadochi cascade rather than break-fusion-bridge, chromothripsis, or chromoplexy.
AI summary · may contain errors
Multimodal foundation models applied to liquid biopsy data could improve sensitivity for tumor-derived signals in blood despite sparse, heterogeneous biomarkers shaped by genetics and comorbidities.
AI summary · may contain errors
Lack of standardization across next-generation sequencing methodologies is a key barrier to precision oncology, limiting reliable genome-informed decisions.
AI summary · may contain errors
Circulating tumour-derived extracellular matrix fragment fingerprints detect protease-generated collagen, proteoglycan, and glycoprotein neo-epitopes with exceptional sensitivity and specificity.
AI summary · may contain errors
LuCaS+ maps NSCLC at single-cell resolution using 2.5 million nuclei from 454 patients, linking tumor subpopulations with high metastatic potential to prognostic value in early-stage lung adenocarcinoma.
AI summary · may contain errors
Baseline PD-L1 and TP53 combined with TSG are linked to very-early progression on first-line osimertinib monotherapy in EGFR-mutant NSCLC, with PD-L1 TPS showing the strongest signal.
AI summary · may contain errors
SPROUT consensus guidelines standardize DNA/RNA next-generation sequencing and methylation profiling timing for children with pediatric solid tumors, based on 41 included studies.
Journals this month
Topics moving, week to 18 Nov 2026
By field